[go: up one dir, main page]

DK0767676T3 - Anvendelse af isolerede domæner af type IV-kollagen til at modificere celle- og vævsvekselvirkninger - Google Patents

Anvendelse af isolerede domæner af type IV-kollagen til at modificere celle- og vævsvekselvirkninger

Info

Publication number
DK0767676T3
DK0767676T3 DK95926149T DK95926149T DK0767676T3 DK 0767676 T3 DK0767676 T3 DK 0767676T3 DK 95926149 T DK95926149 T DK 95926149T DK 95926149 T DK95926149 T DK 95926149T DK 0767676 T3 DK0767676 T3 DK 0767676T3
Authority
DK
Denmark
Prior art keywords
cell
collagen
type
mesoglea
blockage
Prior art date
Application number
DK95926149T
Other languages
Danish (da)
English (en)
Inventor
Michael P Sarras Jr
Billy G Hudson
Original Assignee
Univ Kansas Medical Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Kansas Medical Center filed Critical Univ Kansas Medical Center
Application granted granted Critical
Publication of DK0767676T3 publication Critical patent/DK0767676T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018Culture media for cell or tissue culture
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/505Medicinal preparations containing antigens or antibodies comprising antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/998Proteins not provided for elsewhere

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
DK95926149T 1994-06-30 1995-06-30 Anvendelse af isolerede domæner af type IV-kollagen til at modificere celle- og vævsvekselvirkninger DK0767676T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/268,969 US5567609A (en) 1994-06-30 1994-06-30 Use of isolated domains of type IV collagen to modify cell and tissue interactions
PCT/US1995/008299 WO1996000582A1 (fr) 1994-06-30 1995-06-30 Utilisation de domaines isoles du collagene de type iv pour modifier les interactions cellulaires et tissulaires

Publications (1)

Publication Number Publication Date
DK0767676T3 true DK0767676T3 (da) 2002-05-21

Family

ID=23025295

Family Applications (2)

Application Number Title Priority Date Filing Date
DK95926149T DK0767676T3 (da) 1994-06-30 1995-06-30 Anvendelse af isolerede domæner af type IV-kollagen til at modificere celle- og vævsvekselvirkninger
DK01108470T DK1129721T3 (da) 1994-06-30 1995-06-30 Anvendelsen af isolerede domæner af type IV collagen for at modificere celle- og vævsvekselvirkninger

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK01108470T DK1129721T3 (da) 1994-06-30 1995-06-30 Anvendelsen af isolerede domæner af type IV collagen for at modificere celle- og vævsvekselvirkninger

Country Status (9)

Country Link
US (7) US5567609A (fr)
EP (2) EP1129721B1 (fr)
AT (2) ATE209043T1 (fr)
AU (1) AU3000895A (fr)
DE (2) DE69532835T2 (fr)
DK (2) DK0767676T3 (fr)
ES (2) ES2164160T3 (fr)
PT (2) PT767676E (fr)
WO (1) WO1996000582A1 (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5567609A (en) 1994-06-30 1996-10-22 University Of Kansas Medical Center Use of isolated domains of type IV collagen to modify cell and tissue interactions
US6358735B1 (en) 1995-06-30 2002-03-19 University Of Kansas Medical Center Method for inhibiting angiogenesis and tumors with the isolated NC1 α3 chain monomer of type IV collagen
US6440729B1 (en) * 1995-06-30 2002-08-27 University Of Kansas Medical Center Treating angiogenesis-mediated diseases with the α2 monomer of type IV collagen
EP0878480A1 (fr) * 1997-05-14 1998-11-18 H.W. Prof. Dr. Müller Procédé pour ameliorer la régénération nerveuse
CA2318432C (fr) * 1998-03-27 2003-01-28 University Of Kansas Medical Center Utilisation de domaines isoles de collagene du type iv pour modifier des interactions cellulaires et tissulaires
AU753249B2 (en) * 1998-06-17 2002-10-10 Beth Israel Deaconess Medical Center Anti-angiogenic proteins and methods of use thereof
US6962974B1 (en) 1998-06-17 2005-11-08 Beth Israel Deaconess Medical Center Anti-angiogenic proteins and fragments and methods of use thereof
US7387779B2 (en) * 1998-06-17 2008-06-17 Beth Israel Deaconess Medical Center Anti-angiogenic proteins and fragments and methods of use thereof
US6759047B1 (en) * 1998-06-17 2004-07-06 Beth Israel Deaconess Hospital Corp. Anti-angiogenic proteins and methods of use thereof
US20010018579A1 (en) 1998-12-18 2001-08-30 Walter Klemp Disposable absorbent garment having stretchable side waist regions
AU4187200A (en) * 1999-04-01 2000-10-23 Biostratum, Inc. The use of domains of type iv collagen t inhibit angiogenesis an tumour growth
US6893812B2 (en) * 2000-05-30 2005-05-17 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Three-dimensional ex vivo angiogenesis system
CN100447155C (zh) * 2001-05-23 2008-12-31 中国科学院上海上海生命科学研究院 具有抑制内皮细胞生长活性的重组人内皮生长抑制蛋白
AU2002329643B2 (en) * 2001-07-27 2006-11-16 University Of Kansas Medical Center Crystallized structure of type IV collagen NC1 domain hexamer
WO2004067762A2 (fr) * 2003-01-27 2004-08-12 University Of Kansas Medical Center Structure cristallisee hexamere a domaine nc1 de collagene de type iv
CA2525369A1 (fr) * 2003-05-09 2004-11-25 Frank J. Falco Procedes d'utilisation de gadolinium comme milieu de contraste
US7432413B2 (en) 2005-12-16 2008-10-07 The Procter And Gamble Company Disposable absorbent article having side panels with structurally, functionally and visually different regions
US8491558B2 (en) 2006-03-31 2013-07-23 The Procter & Gamble Company Absorbent article with impregnated sensation material for toilet training
US8057450B2 (en) 2006-03-31 2011-11-15 The Procter & Gamble Company Absorbent article with sensation member
US8664467B2 (en) 2006-03-31 2014-03-04 The Procter & Gamble Company Absorbent articles with feedback signal upon urination
WO2008070131A2 (fr) 2006-12-04 2008-06-12 The Procter & Gamble Company Articles absorbants comprenant des éléments graphiques
US9012160B2 (en) * 2008-06-16 2015-04-21 Abraham Amir Monitoring skin metabolism products for evaluating burn injury
WO2013170433A1 (fr) 2012-05-15 2013-11-21 The Procter & Gamble Company Article absorbant comportant une extrémité de taille caractéristique

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5021404A (en) 1988-04-20 1991-06-04 The Children's Medical Center Corporation Angiostatic collagen modulators
US5567609A (en) * 1994-06-30 1996-10-22 University Of Kansas Medical Center Use of isolated domains of type IV collagen to modify cell and tissue interactions
US6440729B1 (en) * 1995-06-30 2002-08-27 University Of Kansas Medical Center Treating angiogenesis-mediated diseases with the α2 monomer of type IV collagen

Also Published As

Publication number Publication date
ATE262922T1 (de) 2004-04-15
EP0767676B1 (fr) 2001-11-21
EP0767676A1 (fr) 1997-04-16
ES2217050T3 (es) 2004-11-01
DE69524094D1 (de) 2002-01-03
DK1129721T3 (da) 2004-06-28
AU3000895A (en) 1996-01-25
DE69532835D1 (de) 2004-05-06
US6419924B1 (en) 2002-07-16
US5567609A (en) 1996-10-22
US5856184A (en) 1999-01-05
PT1129721E (pt) 2004-07-30
ATE209043T1 (de) 2001-12-15
WO1996000582A1 (fr) 1996-01-11
ES2164160T3 (es) 2002-02-16
US20030013194A1 (en) 2003-01-16
EP1129721B1 (fr) 2004-03-31
US5691182A (en) 1997-11-25
DE69524094T2 (de) 2002-04-18
US6448222B1 (en) 2002-09-10
US6384012B1 (en) 2002-05-07
DE69532835T2 (de) 2005-02-10
PT767676E (pt) 2002-03-28
EP1129721A2 (fr) 2001-09-05
US6680293B2 (en) 2004-01-20
EP1129721A3 (fr) 2001-11-14

Similar Documents

Publication Publication Date Title
DK0767676T3 (da) Anvendelse af isolerede domæner af type IV-kollagen til at modificere celle- og vævsvekselvirkninger
BR9913586A (pt) Processos para controlar bioincrustação em um meio aquoso e para marcar biofilmes e agregados celulares em um meio aquoso
NO894353L (no) Bygningsteknisk styringsenhet med totraads data- og kraftforsyningslinje.
DE69925063D1 (de) Tastatur mit Rückbeleuchtungsanzeige
ES2169495T3 (es) Dispositivo de distribucion de productos fluidos.
DE69633652D1 (de) Pegelschieber für kleine Speisespannungen mit geringem Verbrauch
DE69914053D1 (de) Einrichtung zur Steuerung eines Elektromagneten, mit Erfassung von unbeabsichtigtem Bewegen des beweglichen Kerns eines Elektromagneten
NO911233L (no) Nye retinoider.
DK0995155T3 (da) Konsistens af mikroprocessor-cachelager
DK0914169T3 (da) Materialer til anvendelse i glaukomfiltreringsanordninger
Barker et al. Managing surface water abstraction
DE60026272D1 (de) Verwendung eines Papillarfibroblast-spezifischen Antikörpers als Marker der Hautqualität
BR9905637A (pt) Processo para distribuir energia numa rede de abastecimento de corrente
DE69531217D1 (de) Vorrichtung zum unterbrechen der stromversorgung eines objektes
DE69020100D1 (de) Speiseschaltung für Gleichspannungsregler mit spannungserhöhender Schaltanordnung.
DE69934968D1 (de) Breitbandiger übergang von mikrostreifenleitung auf parallelplatten-hohlleiter
DE69216253D1 (de) 2-(2-benzo b thienyl)-3-methoxyacrylat- und -2-iminoacetat-derivate zur verwendung als pestizide
Jaquet Managing the global environment: The role of the water manager. National report: Switzerland
KR930011940A (ko) 조리기
KR960011621A (ko) 카드 오실장시 카드 파손 방지방법
BR9000481A (pt) Contador com reposicao,iluminavel internamente
GALLAGHER PRICE-INVESTMENT POLICIES OF URBAN WATER AUTHORITIES
Crance Suitability Criteria for Assessment of Instream Flow Needs of Fish
BR0015499A (pt) Codificador de baixa impedância para uso com um medidor de serviços, unidade coletora de dados para um medidor de serviços, dispositivo codificador de baixa impedância, e, medidor de serviços
Gnauck et al. On the water quality management of a river basin with aid of combined models of water quantity and water quality.